# OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery

> **NCT02089113** · PHASE3 · COMPLETED · sponsor: **Ocular Therapeutix, Inc.** · enrollment: 241 (actual)

## Conditions studied

- Post-Surgical Ocular Pain
- Post-Surgical Ocular Inflammation

## Interventions

- **DRUG:** Dexamethasone
- **PROCEDURE:** Placebo Vehicle

## Key facts

- **NCT ID:** NCT02089113
- **Lead sponsor:** Ocular Therapeutix, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-01
- **Final completion:** 2015-03
- **Target enrollment:** 241 (ACTUAL)
- **Last updated:** 2019-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02089113

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02089113, "OTX-14-003: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Ocular Inflammation and Pain After Cataract Surgery". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT02089113. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*